Hermouet et al. [94] envisioned the JAK2 46/1 haplotype as a marker of inappropriate myeloid response to cytokines, leading to an enhanced inflammatory state, myeloid neoplasm, and impaired defense against infection. Here, JAK2 is linked to infection.